Apoptosis is a physiologica l form of death in which cells turn-on an intrinsic genetic program that eventually leads to their destruction in a highly regulated manner. This process renders elimination of "unwanted cells" in the body, and accounts for cellular turnover and homeostasi s of tissues in multicellular organisms. Consequently, an imbalance in the apoptotic rate in a particular tissue can lead to profound effects in the whole organism. Exposure of cells to apoptotic stimuli induces a rapid loss of cell volume (apoptotic volume decrease) that plays a pivotal role in the decision of a cell to undergo apoptosis. Interestingly, the apoptotic volume decrease is driven by changes in ionic uxes across the plasma membrane that promote a decrease in the intracellular ions that ultimately also leads to a reduction in intracellular ionic strength. Despite an intensive research effort however, the cellular and molecular mechanisms that trigger changes in cell volume during apoptosis remain poorly understood . Nevertheless, this apoptotic volume decrease has been shown to be a necessary component of the apoptotic cascade and an important point of modulation for the entire cell death process. In this review, we will focus on the importance of the apoptotic volume decrease in the context of signaling and modulation of programmed cell death.
INTRODUCTION
Programmed cell death is a physiologica l form of death that is crucial in growth, maintenance, and normal development of tissues. For example, apoptosis eliminates reactive lymphocytes from the body after completion of a successful immune response. However, there is a growing number of pathologies linked to abnormal rates of programmed cell death. An "excessive" amount of apoptosis can lead to an irreversible loss of cells and a correspondent pathology, including neurodegenerative diseases (97) , rheumatoid arthritis (28) , and AIDS (19) . In contrast, "insuf cient" apoptosis accounts for accumulation of cells and can lead to tumorigenic growth and cancer (69) , in ammation (7) , and autoimmunity (5) . Understanding the mechanisms that integrate and modulate the apoptotic machinery has been a proli c area of research in the last decade. The search for therapeutic agents targeting cellular apoptotic components is regarded as a promising feature in the therapeutic treatment of a wide variety of diseases (70) . The classical components of the apoptotic network include caspases (a family of cysteineproteases; (83) , death receptors that belong to the tumor necrosis factor receptor (TNFR) superfamily, several adaptor proteins that act as apoptotic initiators, and proteins belonging to the Bcl-2 family. These components are in turn regulated by a diverse range of new signaling molecules that include ions, kinases, phosphatases, transcription factors, and plasma membrane derived lipids that are critical to determine cell death and life decisions.
A large number of cellular processes are regulated by the activation of ionic uxes across the plasma membrane. A classical example are neurons, whose excitability is tightly dependent on transport of ions and other substrates such as amino acids across the plasma membrane. However, ionic changes also account for the initiation and progression of a multitude of physiological processes in nonexcitable cell types. For example, release of insulin by pancreatic cells has been shown to be preceded by opening of ATP-sensitive K channels (2) . In the immune system, K channels play a key role in the rapid response during the activation and cycling of T-lymphocytes upon antigen recognition (16, 17) . Transport of Cl across the plasma membrane constitutes an essential process in the synthesis and secretion of mucus in the lung epithelia, and defects in Cl conductance in pulmonary cells accounts for the development of cystic brosis (42) . Interestingly, apoptosis is not an exception and the apoptotic volume decrease has been found to be coupled to a loss of intracellular K and other ion movements. These ion uxes seem to be a driving force in apoptosis, and may even precede other apoptotic events, such as caspase activation or mitochondrial depolarization (10, 12, 82) .
INDUCTION OF PROGRAMMED CELL DEATH: APOPTOTIC VOLUME DECREASE Interestingly, when in 1972 Kerr, Wyllie, and Currie (37) described the existence of a "different" form of cell death 541 0192-6233/02$3.00 $0.00 other than necrosis, the authors emphasized the loss of cell volume as one of the most striking differences between this type of death and necrotic death. In fact, cell shrinkage is a distinctive characteristic that permits the discrimination between apoptosis from necrosis, and as such can be considered a signature of this programmed cell death process. In contrast, necrosis has been classically considered a pathological form of cell death that provokes cell swelling, organelle destruction, energy dissipation, and physical disruption of the cell membrane that leads to leakage of intracellular constituents into extracellular compartments. This sequence of events in turn promotes in ltration of immune cells and FIGURE 1.-Induction of the cell death program. There are a large number of stimuli that can trigger programmed cell death. Some representative inducers are depicted in this chart, including ligation of the Fas/CD95 receptor, UV treatment, oxidants, and calcium. Activation of the Fas-receptor induces recruitment of the adaptor protein FADD/Mort-1, which subsequentl y recruits the proform of caspase-8, the inititator caspase in this pathway. This process leads to the activation of caspase-8, its release to the cytosol where it proteolytically cleaves and activates other proteins such as pro-caspase-3 and BID. Activation of caspase-3 constitutes a key point of apoptosi s and renders cleavage of critical cellular substrates such as poly(ADP ribose) polymerase (PARP), PKC, fodrin, nuclear lamin, MEKK1, and other substrates. The Fas pathway diverges to the mitochondria through the proteolytic cleavage of BID, a pro-apoptotic member of the BCL-2 superfamily. The truncated forms of BID can be translocated to the mitochondria, and initiate mitochondrial changes characteristic of apoptosis such as mitochondrial membrane depolarization and release of cytochrome c (cyt c) into the cytosol. Other stimuli including, but not limited to, drugs, UV, oxidants, calcium, oncogen e activation (i.e., c-myc), and tumor supressor proteins (i.e., p53) may exert their apoptotic effects by triggering mitochondrial damage and cyt c release. However, it remains unclear whether additional signals emerging from the nucleus trigger cell death signaling in response to DNA damaging agents. Cytochrome c enhances the assembly of a caspase-activatin g complex termed the apoptosome , which is comprised of Apaf-1, cyt c, and pro-caspase-9 (98) . The formation of the apoptosom e presumably facilitates the activation of pro-caspase-9 , which contributes to the downstream activation of caspase-3 and ampli cation of the cell death signal. mediators, enhances in ammatory responses, and can induce proliferative processes due to massive tissue destruction. Although apoptosis can per se lead to pathological conditions, it is nevertheless considered a nonpathologica l form of cell death for the surrounding tissue. During apoptosis cells undergo death in a "silent" way by shrinking and ultimately being engulfed and phagocytized by scavenger cells (75) , a process that globally contributes to the escaping of a potential in ammatory response. Activation of apoptosis occurs via a multitude of pathways that are stimulus-, time-, and dose-dependent. Apoptosis can be induced by a wide variety of both physiological and pathological stimuli (Figure 1 ), which include stimulation of cell surface death receptors such as the Fas/CD95/Apo-1, DNA damaging agents, glucocorticoids, ultraviolet-, and c -radiation, growth factor deprivation, chemotherapeutic drugs, and by a variety of viruses and pathogens. Nevertheless, the intracellular signaling pathways triggered by such death stimuli are also under the inuence of a broad range of other regulatory mechanisms that may eventually determine cell death/life decisions. For example, activation of the Fas/CD95 receptor induces apoptosis in Jurkat T-cells but simultaneous stimulation of both the receptor and protein kinase C leads to the emergence of resistance to cell death in Jurkat T-cells (30) . Cell death induced byexposure of lymphoid cells to death receptor-activators has provided a valuable models to dissect mechanisms of cell volume changes during apoptosis. Cell death receptors belong to the tumor necrosis factor receptor (TNFR) superfamily and embrace receptors such as Fas/CD95, DR3/Apo3, and DR5/Apo2/ TRAIL-R2 (3, 88) that are stimulated by the binding of their respective deathligands. Death receptors share a unique conserved structure that include motifs such as a cysteine-rich extracellular domain, and a cytoplasmic motif termed the "death domain" [DD; (27, 80) ]. Importantly, DDs are essential for signaling cell death upon activation of the receptors by coupling extracellular death stimuli to the activation of intracellular signaling pathways (7) . Death receptors (6, 88) induce apoptosis by recruiting adapter proteins that initiate the postrecruitment of enzymes and signaling molecules that commence the apoptotic cascade. The Fas/CD95 receptor has been one of the best characterized cognates among this family of death receptors. Fas is a 45-KDa cell surface protein expressed as a transmembrane trimer which is highly expressed in the thymus, liver, heart and kidney, and can be activated either by its natural ligand, a trimeric cytokine termed FasL, or with speci c antibodies.
Fas stimulation involves changes in the conformation of the receptor that induce recruitment of FADD/Mort-1 (Figure 1 ), an adaptor molecule containing a DD in its C-terminus that interacts with the receptor presumably through homotypic DD interactions. FADD rapidly recruits pro-caspase-8, which is the initiator caspase of the Fas-pathway, and leads to its proteolytic activation (58) . The interaction of the Fas/CD95 receptor with FADD and pro-caspase-8 is known as the DISC [Death Inducing Signaling Complex; (38) ]. Pro-caspase-8 becomes autoproteolytically cleaved and activated, and leads to the ampli cation of the death cascade through cleavage and activation of downstream caspases such as caspase-3 and proapoptotic molecules such as BID (26, 48) . BID is a 22-kDa pro-apoptotic member of the BCL-2 family that is cleaved by caspase-8 leading to the truncated form (tBID) that is translocated to the mitochondria. Cytochrome c is then released from mitochondria and downstream caspases are activated.
MECHANISMS OF APOPTOTIC VOLUME DECREASE Cell Volume Regulation
Most cells have the ability to modulate their volume upon osmotic disturbances through activation of cellular mechanisms that are energy-demanding. Although apoptotic cell shrinkage is reminiscent of osmotic cell shrinkage, the factor(s) that trigger loss of cell volume during apoptosis remain to be elucidated. The plasma membrane is armed with a battery of ionic channels and transporters that contribute to the maintenance of the plasma membrane potential, counteract continuous ionic and osmotic imbalances, and transport substrates against gradient concentrations in an ion-coupled manner. Osmotic insults generally stimulate cell volume regulatory responses. Induction of a hyperosmotic shock occurs when cells are exposed to a hypertonic medium that induces an acute cell shrinkage response (34) . This cell shrinkage is mainly driven by a rapid loss of intracellular water that is the major determinant of the physical cell volume, and is followed by a relatively slower recovery of the cell size in a process known as RVI (regulatory volume increase) response.
The cell volume recovery process takes place through a coupled activation of the Na /H antiporter and a Na /K /2Cl cotransporter, and a Cl /HCO 3 that yields a net in ux of NaCl and water. Moreover, the uptake of other organic osmolytes such as amino acids (67) also contributes to the cell volume recovery during RVI by increasing the intracellular osmolarity, and thus water in ux. In contrast, hyposmotic stress results in rapid cellular swelling, followed by activation of RVD (regulatory volume decrease) mechanisms, in which a net ef ux of K , Cl , and Na plays a predominant role in this process. The nature of the speci c cellular sensors of osmotic changes remain unknown, although mechanical changes in the plasma membrane and macromolecular crowding have been suggested to be effective inductors of volume changes in mammalian cells (15) .
Apoptotic Volume Decrease and Cellular Implications
Research in several laboratories including ours has shown that induction of cell shrinkage using osmotic insults in cells can activate apoptosis (9, 55, 73) . These studies have been useful to establish the concept that apoptotic cell shrinkage shares an arsenal of cellular mechanisms that are used by cells to respond to osmotic changes. However, although activation of ionic movements by osmotic changes has a wellde ned 'stress' stimulus, there is a lack of knowledge on the mechanism that couples cell death program stimulation to cell shrinkage. Moreover, although osmotic responses in a cell population seem to be relatively synchronized, apoptotic cell shrinkage tends to rather display a hetereogenous response.
Regardless of the stimulus used to trigger the apoptotic response, a common feature of cells undergoing apoptotic cell death is the loss of cell volume that discriminates it from necrosis. The loss of cell size or cell volume in cells upon an apoptotic stimulus can be generally detected in the early phase of the cell death program. These changes in cell size are detected by conventional microscopy and quanti ed in cell populations by ow cytometric analyses of forwardscatter light ( Figure 2) . Cell shrinkage appears to result from combined changes in ion channel uxes, plasma membrane transporter activity, water ef ux, and cytoskeletal reorganization. Cell shrinkage is an energy demanding process that can affect a number of cellular, biochemical, and metabolic processes in the physiology of normal cells. However, both the trigger-signal and the exact constituents of the apoptotic cell shrinkage network remain to be elucidated. Along with the loss of cell volume, initiation of the cell death program results in the activation of caspases, a family of cysteine-aspartate proteases that are responsible for the cellular proteolysis at asparagine residues of a large variety of proteins (83) . Caspases reside as cytosolic inactive pro-enzymes and their activation follows a hierarchical organization that spans from initiator caspases such as caspase-8, to other executioner caspases, similar to the complement activation cascade. Caspases are generally activated upon cleavage of their pro-forms and formation of the active enzymes through oligomerization of the cleaved fragments. Importantly, caspases also target and activate endonucleases, enzymes responsible for internucleosomal DNA fragmentation that ultimately contributes to the apoptotic nuclear changes and nucleic acid destruction (54) . Because in many instances caspase and nuclease activity cannot be detected prior to the apoptotic cell shrinkage, it seems possible that the activity of these 2 classes of enzymes is somewhat regulated by both changes in cell volume and ionic uxes.
Glucocorticoid-induced cell death in lymphoid cells has provided a nice model to show relationships between volume changes and apoptotic features. Glucocorticoids are commonly used in the treatment of in ammatory diseases and several types of cancer. One of their anti-in ammatory actions is related to their ability to bind the glucocorticoid receptor (GR) and to antagonize pro-in ammatory signals activated by the transcription factor NFj B (56) . Glucocorticoids are also potent stimulators of lymphoid cell death, but the mechanisms by which glucocorticoids trigger apoptosis are poorly understood. In vivo administration of glucocorticoids in adrenalectomized rats causes thymic regression primarly due to induction of apoptosis in thymocytes (20) . When the same cells are treated ex vivo with dexamethasone, a synthetic analogue of cortisol, programmed cell death is activated in a dose-dependent manner through a mechanism inhibitable by a GR antagonist such as RU486 (21) . Interestingly under these conditions, thymocytes display a dose-dependent loss of cell volume (81) due in part to a loss of water and ion content in parallel with an increase of DNA fragility. Further studies on cell volume changes in glucocorticoid induced apoptosis have provided a considerable amount of information on the signaling and regulation of this cell death pathway. Our laboratory has shown that treatment of lymphocytes with dexamethasone induces a marked cell shrinkage among the cell population analyzed by ow cytometry (12) .
A closer examination of the cell population revealed that only the shrunken subpopulation of cells displayed fragmented DNA, suggesting that cell shrinkage and DNA degradation might occur in parallel during apoptosis. A similar relationship was observed in rat primary thymocytes cultured in the presence of dexamethasone. These shrunken thymocytes displayed a signi cant decrease in the intracellular K content and an increase of caspase-3-like activity. These results, together with the fact that DNA degradation in freshly isolated thymocyte nuclei was attenuated by elevated concentrations of KCl present in the incubation medium (35) , suggested that the intracellular ionic strength might be regulating these two apoptotic enzymatic activities. Consistent with this premise, caspase and nuclease activities measured in vitro were dependent on the concentration of potassium in the reaction buffer, i.e., a physiological concentration of K inhibited enzymatic caspase and nuclease activities, and these enzymes were activated by decreasing K concentration in the buffer (35) . Indeed, Walev and colleagues (87) described the direct in uence of K movement and local K concentrations on the action of interleukin-1b -converting protease (ICE) in human monocytes. These ndings have led to the novel concept of cell shrinkage and ionic changes as pivotal mechanisms to set intracellular ionic strength conditions necessary for the activation of apoptotic enzymatic activities. More recently, studies from our laboratory have shown that apoptotic cell shrinkage, K ef ux and mitochondrial depolarization are tightly sequenced events during Fas-induced apoptosis (10) , and that inhibition of initiator caspases blocks Fas-induced cell shrinkage and K ef ux (85) . However, cell shrinkage and K ef ux still occur upon caspase-inihibition in UV-induced cell death (85) , suggesting that the modulation of cell volume changes during cell death is apoptotic-stimulus dependent.
Loss of Ions During Apoptosis: The Role of Potassium, Sodium, and Chloride
A number of studies in the early 1990s began to show the speci c involvement of ion movement in apoptotic cell shrinkage. An important concept derived from a decade of investigation is that ne ionic movements are critical for the regulation of cell death not only in classically ion-modulated cells such as neurons, but also in other cell types including lymphoid and hepatic cell lineages. Among the current literature, ef ux of K has been the most critical ion-related movement associated with apoptotic volume decrease, and is considered an active component in apoptosis. The loss of intracellular water and ions during apoptosis was initially reported by Klassen and colleagues (39) in rat thymocytes undergoing apoptosis under the in uence of glucocorticoids. This loss of cell volume was partially attributed to the speci c activation of Ca 2 -sensitive K or Cl channels (64) . A reduction in the intracellular potassium and sodium content also occurs during Fas/CD95-induced apoptosis. This decrease in ion content correlates with both a drop in the intracellular ionic strength and activation of caspase-3 (12) . Using Jurkat T-cells loaded with radioactive rubidium ( 86 Rb), which is a isotopic analog of potassium, our laboratory showed that the decrease in intracellular [K ] was attributed to a net ef ux of K via an unidenti ed potassium channel(s) (11, 30) . Moreover, treatment of cells with elevated extracellular [K ] effectively inhibited Fas-induced cell shrinkage and DNA fragmentation (12) . More recently, these same K -perturbations have been used to show that high extracellular [K ] inhibits cytochrome c release, caspase-8 activation, and formation of the apoptosome during Fas-induced apoptosis (82) .
Several studies have contributed to further clarify the speci c role of K channels during apoptotic cell death. Treatment of cells with potassium channel blockers such as 4-aminopyridine (4-AP), sparteine or quinidine abrogated cell shrinkage in human eosinophils induced to undergo apoptosis by cytokine withdrawal (8) . Using patch-clamp techniques, Wang et al (89) showed that exposure of human leukemia cells (ML-1) to UV radiation for 1 minute was sufcient to evoke a K current sensitive to 4-AP. Interestingly, treatment of cells with 4-AP had a death-protective effect on the UV-irradiated cells (89) . Additionally, Nietsch et al (62) have detected a rapid activation of K and Cl channels that are triggered upon treatment of murine hepatoma-derived cells (HTC) with TNF-a . These currents also seemed to be sensitive to K channel blockers such a Ba 2 and quinine, and Cl channel blockers such as NPPB and DPC. Similarly, induction of cell death with TNF promoted a relatively rapid (2h) cell shrinkage in neuronal (NG108-15) and monocytic cells (U937). This effect appeared to be inhibited by Ba 2 and quinine, and by a variety of Cl channel blockers (NPPB, DIDS, SITS, and mi umic acid) but not by the general caspase inhibitor z-VAD-fmk (52) . This later study supports data by other laboratories showing that apoptotic volume decrease may occur upstream and/or independently of caspase activation (12, 35) .
Exposure of HTC cells to tumor necrosis factor (TNF) was shown to increase outwardly rectifying K and Cl currents in a Ca 2 -dependent manner, and conversely, inhibition of these same channels reduced TNF-induced cell death (62) . However, in other cell types such as astrocytes, TNF-a has been shown to be a potent inhibitor of inwardly rectifying K currents (40) . Ef ux of K through outward currents also seems to contribute to the depletion of K from mouse cortical neurons undergoing apoptosis via activation of the N-methyl-D-aspartate (NMDA)-receptor, and also to actively participate in the cell death process following brain ischemia (96) . Consistent with the concept of a loss of intracellular K as an apoptosis "prerequisite" are the results from studies in neurons and lymphocytes, where high extracellular [K ] can effectively attenuate the loss of K , cell shrinkage, and apoptosis (12, 30, 82, 95) . Interestingly, the widely expressed n-type voltage-gated K channels presumably shut down upon treatment of cells with different apoptotic stimuli such as Fas-receptor activation, ceramide or oxidative stress treatment (23, 33, 77, 79) . Because these voltage-gated K channels are essential for the recovery of the plasma membrane potential upon depolarization, and are clearly involved in mitogenic processes such as T-cell activation (16) , it appears that the apoptotic cellular machinery not only drives cells, toward cell death, but also "saves" cellular energy by preventing "futile" cell division.
Other Ionic Transporters and Cell Death
Our laboratory has recently shown that the plasma membrane is depolarized during Fas-and glucocorticoid-induced cell death (11, 53) . Using different approaches, we and others have found that inactivation of the plasma membrane Na /K -ATPase may in part be responsible potential for changes of both intracellular [Na ] and [K ] during apoptosis (11, 63) . Speci cally, both inhibition of the functional activity and decrease in the protein expression of the pump was found in lysates from Fas-treated cells (11) . Inactivation of the pump renders a net loss of intracellular K and concomitant increase of Na that may be responsible for plasma membrane depolarization during early stages of Fas-induced cell death in lymphocytes. However, other additional ionic changes may also contribute to depolarize the cells during apoptosis. Interestingly, simultaneous treatment of cells with anti-Fas and Na /K -ATPase inhibitors such as ouabain (a cardiac glycoside) enhanced apoptotic death effects, whereas inhibition of the Na /K -ATPase with ouabain alone did not induce cell death in Jurkat cells (11) . In other models, reduction of intracellular potassium using agents such as nigericin, valinomycin (both ionophores), or ouabain also sensitizes T-cell lines to TNF-induced apoptosis (66) . Inhibition of the Na /K pump with bufalin has been shown to be a suf cient stimulus for inducing apoptosis in human monocytic cells (43) , raising the possibility that the role of this pump during cell death is cell-tissue speci c, or alternatively, bufalin might be targeting other cellular components.
Other channels such as the outwardly rectifying Cl channel (ORCC), are activated in Jurkat T-cells upon activation of the Fas receptor (78) . This activation results in an ef ux of HCO 3 and acidi cation of the cytosol. Moreover, inhibition of the Na /H antiporter during Fas-induced apoptosis in Jurkat T-cells has been shown to contribute to Fasinduced acidi cation (44) . Such cytosolic acidi cation has been proposed to be a prerequisite for endonuclease activity (78) , which can be prevented by ORCC blockers such as 1,9dideoxyforskolin (ddFSK) and NPPB. Although the loss of Cl ions during apoptosis suggested by Szabo and colleagues might indirectly account for the increase in endonuclease activity, cytosolic Cl loss does not seem to regulate nuclease activity directly (68) .
In addition to the ef ux of ions, decay in intracellular concentrations of amino acids that can act as osmolytes such as taurine have been reported to contribute to the apoptotic loss of cell volume. A net release of taurine was observed as early as 1 hour after stimulation of the Fas receptor in Jurkat cells and was coincident with the initiation of cell shrinkage, suggesting that release of intracellular taurine contributes to the apoptotic loss of cell volume (45) , as opposed to triggering this response.
SIGNAL TRANSDUCERS OF APOPTOTIC CELL SHRINKAGE
A complex network of signal transduction mechanisms contribute to orchestrate and modulate apoptotic cell death at very discrete stages of the death process. Some mechanisms initiate apoptosis, yet others contribute to either accelerate or inhibit cell death in response to speci c death signals. Importantly, conditions that in uence cell volume and ion changes during apoptosis have a direct impact on the entire apoptotic cascade. Because of the interest in modulating apoptosis as a target for the intervention in a number of diseases (70) , efforts in the basic research of signaling mechanisms that regulate apoptosis in cells has become an active area of investigation.
Tyrosine Kinases
A large number of intracellular signaling pathways are activated by tyrosine kinase phosphorylation . A classic example is found in proliferative and transformation pathways stimulated by activation of cell surface receptors such as the epidermal growth factor receptor (EGFR) (92) . Tyrosine kinase activity is also induced during cell volume regulatory responses such as the RVI in human leukocytes upon osmotic stress (41) and in opening of chloride channels in lymphocytes (46) . However, phosphorylation of proteins at tyrosine residues has also been shown to contribute to the complex regulation of cell death. Activation of the Fas receptor was rst shown to induce a rapid tyrosine-phosphorylatio n of a variety of cellular proteins (24) . The effectiveness of some tyrosine-kinase inhibitors in promoting cell survival in Fas/CD95-stimulated cells suggested that tyrosine phosphorylation may be a necessary signal in Fas-induced apoptosis. Speci cally, studies on hematopoietic cells revealed the speci c activation of the Src-family tyrosine kinases p56Lck and p59Fyn upon Fas stimulation (76) . Similarly, other laboratories reported that T-lymphocytes from Fyn-de cient mice were found to be less sensitive to killing by Fas activation (4) . In this same study, a possible physical association of the Fas-receptor with p59Fyn-independen t of Fas-activation was also shown to occur. Interestingly, an important target of tyrosine phosphorylation in Jurkat T-cells are n-type K channels, which become rapidly phosphorylate d and inactivated upon Fas-stimulation (77) . In addition, volume regulatory ORCC channels can be phosphorylate d and activated by the p56lck tyrosine kinase, probably contributing to cytosolic acidi cation during Fasinduced cell death (78) . Recently, p56Lck and p59Fyn have been reported to be cleaved in their N-terminal domain and to relocate during apoptosis by a caspase-3-dependent mechanism (50, 72) . In general, activation of tyrosine kinases occurs at the level of the plasma membrane. However, their cleavage at the N-terminus leads to relocation of these kinases to the cytosol (50, 72) , which indicates that Src may also exert multiple effects during apoptosis.
Protein Kinase C
Protein kinase C (49) (PKC) is a family of serine/threonine kinases that encompasses 3 different subfamilies: classical PKCs (cPKC; a , b I, b II and c isotypes), novel PKCs (nPKC's; d , e , h , g ), and atypical PKCs (aPKC's; f , i , and k isotypes). Classical PKC isotypes require Ca 2 and diacylglycerol (DAG) for maximal activation while nPKC's are Ca 2 -independent, but require DAG mobilization for their activation. In contrast, aPKC isotypes are both Ca 2 and DAG independent (61) . PKCl or PKD (human and mouse isoforms, respectively) constitute their own group due to their unique structure and regulatory properties.
PKC expression and activity has been shown to play a critical role in the control of apoptosis. Stimulation of PKC with the tumor-promoter 12-O-tetradecanoyl-phorbol 13-acetate (PMA) or with the nontumor promoter bryostatin-1 results in the attenuation of Fas-induced cell death in Jurkat T-cells, whereas treatment of the same cells with speci c PKC inhibitors accelerates the death process (30, 74) . Interestingly, treatment of U937 cells with PMA alone induces apoptosis (60) . Primary thymocytes treated with ionomycin, a Ca 2 ionophore, undergo apoptosis. However, moderate simulation of the cells with ionomycin and PMA has a suppressive effect on thymocyte apoptosis. Spontaneous and glucocorticoid-induced apoptosis of freshly isolated mouse thymocytes can be inhibited by PKC activators within a few hours of treatment, although longer exposure appears to result in cytotoxicity (71) . Several PKC isotypes are cleaved and activated by caspase-3 (22, 25) . However, our laboratory showed that in Jurkat T-cells, PKC activation with PMA or bryostatin-1 blocks Fas-induced changes of cell volume, mitochondrial potential, and DNA fragmentation, while PKC inhibition with bisindolylmaleimides such as Gö6976 and GF109203X results in augmentation of these apoptotic features ( Figure 2 ) suggesting that PKC isotypes control early stages of the Fas-induced cell death program (30) . Although PMA can stimulate mitogenic events through activation of transcription factors such as AP-1 (jun/fos), this protective effect of PMA and bryostatin on Fas-induced cell death correlated with a relatively rapid mechanim that inhibits Fasreceptor activation (31) . In addition, this study showed that PKC activation can inhibit both Fas-induced cell shrinkage and potassium ef ux. However, because PKC exerts a profound control on Fas-receptor signaling (31) it is also possible that PKC regulates Fas-induced ionic changes through an indirect mechanism. It should be mentioned that other effects of PKC on apoptosis signaling take place during downstream processes of apoptotic pathways and by transcriptional mechanisms (32) , including the up-regulation of Fas receptor levels and sensitization of cells to Fas-induced cell death (90) .
Mitogen-Activated Protein Kinase Regulation
Mitogen-activated protein kinases (MAPK) are serine/threonine kinases typically subdivided in three groups: Extracellular-signal regulated protein kinase (ERK), c-junterminal kinase (JNK), alternatively named stress-activated protein kinase (SAPK), and p38 (47) . This family of kinases has diversi ed biological effects and is involved in both proand anti-apoptotic pathways through phosphorylation of speci c proteins and transcription factors. Both JNK and p38 have been shown to regulate apoptosis, although the critical step in determining their impact in cell death seems to be the balance between the 2 kinases, especially in neuronal cells (94) . In a number of reports, p38 kinase was shown to be activated by ceramide i.e., (13) , and by Fas/CD95 stimulation in a caspase-dependent manner (36) . However, other studies failed to detect JNK or p38 cleavage by caspases in Fas, UV or etoposide-induced apoptosis in Jurkat T-cells (84, 93) , suggesting that JNK/p38 activation may be caspase-dependent but through an indirect mechanism.
More recently, Ozaki et al showed that although caspases were necessary for p38 activation during calphostin C-induced apoptosis, this activation was not required for the progression of the apoptotic pathway (65) . The p38 kinases are sensitive to oxidative, osmotic, and environmental stress, and are particularly interesting when considering the crossroads between apoptosis and osmotic responses. Rapid activation of p38 through phosphorylation occurs under hypertonic stress, a cellular insult that induces a rapid cellular shrinkage (29) . Although the role of p38 in cell volume regulation has been extensively reported, the exact substrates of p38 responsible for cell volume responses are not known. Potential substrates suggested by these authors included the system A amino acid transporter and the Na -dependent inositol cotransporter, both highly implicated in volume-regulatory responses of mammalian cells. However, the linkage between cell volume regulation, p38 and apoptotic cell shrinkage has not been clearly established. Interestingly, McLaughlin et al have recently reported the activation of K currents upstream of caspases associated with an increase in p38 phosphorylation during neuronal apoptosis induced by oxidative stress (57) . This report supports the results by other laboratories on the notion that apoptotic ionic changes may precede caspase activation during apoptosis (12, 35, 52) .
Serum Glucocorticoid Kinase
The serum glucocorticoid kinase (SGK) is a widely expressed serine/threonine kinase that can be transcriptionally up-regulated by glucocorticoids and serum (91) . Four years after its cloning, Waldegger and colleagues (86) showed that mRNA levels of the human isoform (h-SGK) were significantly induced in HepG2 cells upon hyperosmotic stress. Moreover, SGK has been proposed to modulate sodium channels (1, 18) . Despite the effects of SGK in both glucocorticoid response and ion cell volume regulation, a direct association between these 2 pathways has not been established. Greenberg and colleagues (96) have recently pointed to the similarities between SGK and Akt (also called PKB), a kinase whose activation induces a cell survival response (14) . In addition, it has been recently shown that some anti-apoptotic effects of the glucocorticoid receptor rely on the ability of the receptor to upregulate SGK (59) . In summary, although some studies directly point to a SGK component in glucocorticoid signaling, cell volume regulation, and apoptosis, evidence to support a de ned link between cell volume changes in apoptosis and the role of SGK remain unclear.
CONCLUDING REMARKS
The apoptotic volume decrease is a distinctive feature of programmed cell death. This loss of cell size occurs at a relative early stage of the cell death program and is a well de ned signature of apoptosis. Apoptotic volume decrease is driven by changes in ion uxes across the plasma membrane, and ionic channels have been proposed to facilitate ionic efux/in ux during apoptosis. In particular, loss of intracellular K has been extensively reported to occur in different apoptotic models. However, as research in this eld advances, it seems that the ionic entities responsible for such volume changes during apoptosis, as well as the regulatory molecules that modulate the process, may be both tissue-and apoptotic stimulus-speci c. In view of the pivotal role that cell shrinkage plays in caspase activation and apoptotic nuclease activity, unveiling the nature of the molecules responsible for the apoptotic cell volume decrease and ionic changes will help to understand some of the most important mechanisms that orchestrate programmed cell death. Speci cally, the discovery of ionic channels associated with apoptotic cell shrinkage, as well as the signal(s) that link the initiation of apoptosis to the opening of these channels is regarded as a challenging and exciting approach to better understand critical points of the regulation of cell death. Finally, the use of speci c compounds targeting ionic movements involved in cell death, may be of interest in the therapeutic intervention of diseases related to disregulation of apoptosis.
